Anna Linda Zignego

15PUBLICATIONS
117CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Political economy and social changeImmunogenetics (incl. genetic immunology)Molecular targetsOther education not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 13, 2026
The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders.

|Feb 26, 2025
The Key Importance of Screening Underprivileged People in Order to Achieve Global Hepatitis Virus Elimination Targets.

Laura Gragnani, Monica Monti, Irene De Giorgi

|Jul 29, 2024
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemic.

Maria Paola Tramonti Fantozzi, Luca Ceccarelli, Davide Petri

|Feb 16, 2023
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity.

Laura Gragnani, Marcella Visentini, Serena Lorini

|Jun 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi.

Michele Merli, Sara Rattotti, Michele Spina

|Feb 26, 2022
Reply.

Anna Linda Zignego, Laura Gragnani, Loreta A Kondili

Pageof 3

Frequent Collaborators

10 joint publications

Laura Gragnani

4 joint publications

Cristina Stasi

3 joint publications

Loreta A Kondili

3 joint publications

Silvia Marri